Relationship between insulin resistance and subclinical atherosclerosis in individuals with and without type 2 diabetes mellitus

被引:30
作者
Fakhrzadeh H. [1 ]
Sharifi F. [1 ]
Alizadeh M. [1 ]
Arzaghi S.M. [1 ]
Tajallizade-Khoob Y. [1 ]
Tootee A. [2 ]
Alatab S. [2 ]
Mirarefin M. [1 ]
Badamchizade Z. [2 ]
Kazemi H. [3 ]
机构
[1] Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Elderly Health Research Center, No 4th, Ostad Nejatollahi Street, Enghelab Avenue, Tehran
[2] Tehran University of Medical Sciences, Endocrinology and Metabolism Research Center, Tehran
[3] Pediatrics, Shahed University, Faculty of Medicine, Tehran
关键词
Atherosclerosis; Cardiovascular diseases; Coronary artery calcium score (CACS); Diabetes mellitus; Flow mediated dilation (FMD); HOMA-IR; Insulin resistance;
D O I
10.1186/s40200-016-0263-5
中图分类号
学科分类号
摘要
Background: Insulin resistance is of utmost importance as an underlying mechanism for increased risk of cardiovascular disease (CVD). We assessed the association between Homeostatic Model Assessment (HOMA-IR) and two surrogate subclinical atherosclerosis markers (SCA) among individuals with and without type 2 diabetes (DM), those who did not have any clinical presentation of the CVD. Methods: In a cross-sectional study, 208 participants (105 diabetics and 103 non-diabetics) were enrolled from referred patients with diabetes to an academic outpatient clinic and their non-diabetic relatives in-law. Fasting serum levels of insulin, blood glucose and lipid profile, were measured. Anthropometric and blood pressure were measuremented standardly. Body Mass Index (BMI) and Homeostatic Model Assessment-Insulin Resistance (HOMA-IR) index were calculated. Coronary Artery Calcium Score(CACS) was measured using a Multi-Detctor CT scanner. Flow mediated dilation (FMD) was measured using bimode ultrasonography (with linear transducer 13,000 MHZ). Univariate and multivariate logistic regression models were used to evaluate the association between these SCA markers and HOMA index in adjusting models. Results: CACS and HOMA-IR were higher and FMD was lower in diabetic participants than non-diabetic ones (P < 0.01) In a stepwise logistic regression model, CACS and FMD were associated with HOMA-IR (odds ratio = 1.778; 95 % confidence interval (CI): 1.211-2.726 and odds ratio = 1.557; 95 % CI: 1.601-2.275, respectively) in non-diabetics but not among diabetic participants. Conclusions: CACS and FMD are related to insulin resistance among non-diabetic individuals, but we could not find this relationship among diabetic patients. © 2016 The Author(s).
引用
收藏
相关论文
共 38 条
[1]  
Chan J.C., Malik V., Jia W., Kadowaki T., Yajnik C.S., Yoon K.H., Et al., Diabetes in Asia: epidemiology, risk factors, and pathophysiology, JAMA, 301, pp. 2129-2140, (2009)
[2]  
Beauloye V., Zech F., Tran H.T., Clapuyt P., Maes M., Brichard S.M., Determinants of early atherosclerosis in obese children and adolescents, J Clin Endocrinol Metab, 92, pp. 3025-3032, (2007)
[3]  
Stevens R.J., Kothari V., Adler A.I., Stratton I.M., The UKPDS risk engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS 56), Clin Sci (Lond)., 101, pp. 671-679, (2001)
[4]  
Wang C.C., Reusch J.E., Diabetes and cardiovascular disease: changing the focus from glycemic control to improving long-term survival, Am J Cardiol, 6, 9, pp. 58B-68B, (2012)
[5]  
Hanley A.J., Williams K., Stern M.P., Haffner S.M., Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study, Diabetes Care, 25, pp. 1177-1184, (2002)
[6]  
Aminot-Gilchrist D.V., Anderson H.D.I., Insulin resistance-associated cardiovascular disease: potential benefits of conjugated linoleic acid, Am J Clin Nutr, 79, pp. 1159S-1163S, (2004)
[7]  
Mather K., Anderson T.J., Verma S., Insulin action in the vasculature: physiology and pathophysiology, J Vasc Res, 38, pp. 415-422, (2001)
[8]  
Temelkova-Kurktschiev T.S., Koehler C., Leonhardt W., Schaper F., Henkel E., Siegert G., Et al., Increased intimal-medial thickness in newly detected type 2 diabetes: risk factors, Diabetes Care, 22, pp. 333-338, (1999)
[9]  
Arad Y., Goodman K.J., Roth M., Newstein D., Guerci A.D., Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: the St. Francis Heart Study, J Am Coll Cardiol, 46, pp. 158-165, (2005)
[10]  
Detrano R., Guerci A.D., Carr J.J., Bild D.E., Burke G., Folsom A.R., Et al., A. Coronary calcium as a predictor of coronary events in four racial or ethnic groups, N Engl J Med., 358, (2008)